BDX vs CRL Stock Comparison

Compare BDX and CRL across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.

Market data as of Sep 11, 2026 market close· AIQ score gap 11 points
BDX
Healthcare
vs
CRL
Healthcare
BDX
Becton, Dickinson and Company
Leads
Price
$178
Day move
+0.81%
AIQ Score
48/100
Best edge
Value
Sector
Healthcare
CRL
Charles River Laboratories International, Inc.
Price
$278
Day move
+1.93%
AIQ Score
37/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between BDX and CRL?

BDX leads the current stock comparison as Becton, Dickinson and Company, with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Becton, Dickinson and Company vs Charles River Laboratories International, Inc.

Data as of Sep 11, 2026· market close· Healthcare· Coverage 66/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

BDX leads

BDX leads by 11 AIQ points, primarily on Value and Quality.

Competitive: 4 of 6 evidence groups support BDX, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Stable
BDX

Becton, Dickinson and Company

Leads
AIQ Score
48/100
AIQ Edge Score
5/10
CRL

Charles River Laboratories International, Inc.

AIQ Score
37/100
AIQ Edge Score
2/10

The Algovestiq AIQ Score currently favors BDX over CRL, 48 versus 37 as of Sep 11, 2026. BDX's advantage is driven primarily by stronger value and quality, while CRL holds the stronger risk resilience profile. BDX also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor BDX today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. BDX lead: Stable — the AIQ differential has held near 11 points over 30 sessions.

Compare Becton, Dickinson and Company and Charles River Laboratories International, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price-return comparison using available daily close history.

BDX
-31.8%
CRL
-36.7%

Total return comparison

Growth of $10,000

BDX $6,822 · CRL $6,331

Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.

Compare BDX and CRL against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BDX advantage
0
CRL advantage
  • Value63 vs 42
    BDX +21
  • Quality44 vs 29
    BDX +15
  • Risk Resilience46 vs 50
    CRL +4
  • Momentum37 vs 34
    Even

4 of 6 evidence groups favor BDX. BDX’s edge is concentrated in value and quality; CRL keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.

BDX-1 AIQ

Largest factor move: Momentum -3

New signals

  • BB Lower Band Breach bullish, volatility, short horizon
  • Keltner Channel Breakdown bearish, volatility, short horizon
  • RSI Oversold - Potential Bounce bullish, momentum, short horizon
CRL-2 AIQ

Largest factor move: Momentum -6

New signals

  • BB Lower Band Breach bullish, volatility, short horizon

BDX's lead widened by 1 AIQ points in the latest snapshot.

Deeper signal detail for each name lives on its own signals page — BDX and CRL both carry a full feed there.

The central trade-off

BDX (Becton, Dickinson and Company): the stronger current systematic profile, led by value and quality.

CRL (Charles River Laboratories International, Inc.): the counter-case, on risk resilience, technicals — but at materially higher volatility, 29.6% against 23.1%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BDX

BDX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

BDX

BDX on combined revenue and EPS growth.

Value

BDX

BDX on the peer-relative Value factor, by 21 points.

Momentum

Even

The two are level on Momentum.

Lower downside

CRL

CRL on Risk Resilience, by 4 points.

Analyst upside

BDX

BDX on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBDXCRLNote
Implied upside to target+4%-11.4%BDX has more room
Target dispersion+27.6%+43.8%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering810Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor BDX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBDX48 vs 37
FundamentalsBDXon balanceEPS growth 223.4% vs 90%; TTM ROE 3.8% vs -7.7%; gross margin 46.1% vs 32.2%; operating margin 9.8% vs 12.3% — BDX takes 3 of 4 decided legs, not all of them
ValuationBDXValue 63 vs 42
TechnicalsCRLPrice vs 50-day 3.7% vs 7.9%; vs 200-day 2.9% vs 35.2%
Risk ResilienceCRLRisk Resilience 46 vs 50
Analyst expectationsBDXTarget upside 4% vs -11.4%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BDX and CRL and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 11 points.
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BDX.

How the comparison changed

119 daily snapshots · May 4 Sep 10

BDX lead: Stable — the AIQ differential has held near 11 points over 30 sessions.

May 4BDX leads above the line · CRL leads belowSep 10
Today
BDX +11
48 vs 37
7 sessions ago
BDX +13
55 vs 42
30 sessions ago
BDX +10
59 vs 49
90 sessions ago
BDX +6
56 vs 50

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BDXConflicted

3 bullish / 3 bearish, conflicted

  • Death Cross Active bearish, trend, long horizon (0.04%)
  • BB Lower Band Breach bullish, volatility, short horizon
  • Keltner Channel Breakdown bearish, volatility, short horizon
CRLConflicted

4 bullish / 1 bearish, conflicted

  • Golden Cross Active bullish, trend, long horizon (27.75%)
  • BB Lower Band Breach bullish, volatility, short horizon
  • EMA Ribbon Expansion Bullish bullish, trend, medium horizon

BDX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BDXDivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +0.81%, AIQ -1 points).

CRLDivergence

Price is up while the AIQ Score moved down 2 points over the same session — price and model disagree (price +1.93%, AIQ -2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CRL closes the Value gap — currently 21 points behind, the largest single contributor to BDX's edge.
  2. 2CRL generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
  3. 3BDX's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
  4. 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

BDX leads on balance
MetricBDXCRL
Revenue growth (YoY)5.7%0.8%
EPS growth (YoY)223.4%90%
Gross margin46.1%32.2%
Operating margin9.8%12.3%
Return on equity (TTM)3.8%-7.7%
Debt to equity0.691.07

Performance

CRL leads 4 of 6 windows
MetricBDXCRL
1 week (5 sessions)-5.9%-6.4%
1 month (20 sessions)-3.9%-4%
3 months (63 sessions)19.4%46.5%
6 months (126 sessions)8.1%61.6%
Year to date-9.1%36.9%
1 year (252 sessions)-7.9%68.5%

Technicals

CRL has the stronger structure
MetricBDXCRL
RSI (14)28.533.9
ADX (14)39.635.2
Price vs 50-day3.7%7.9%
Price vs 200-day2.9%35.2%
Volatility (1M, annualized)23.1%29.6%

Risk

CRL is the more resilient
MetricBDXCRL
Beta0.391.25
Sharpe ratio-0.221.35
Sortino ratio-0.272.11
Max drawdown-33%-33.9%
Current drawdown-16%-8.6%
Annualized volatility30.6%46%
Value at risk (95%)-2.3%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BDX or CRL?

On the Algovestiq AIQ Score, BDX is the stronger of the two as of Sep 11, 2026, scoring 48 against CRL's 37. The edge comes from value and quality. CRL is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BDX or CRL the better buy right now?

BDX carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor BDX over CRL?

The composite weights Quality, Value, Momentum and Risk Resilience. BDX leads Value by 21 points; BDX leads Quality by 15 points; CRL leads Risk Resilience by 4 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BDX or CRL?

Analyst price targets imply +4% upside for BDX and -11.4% for CRL, so the Street currently favors BDX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BDX or CRL?

BDX is the better-valued of the two on the peer-relative Value factor. BDX on the peer-relative Value factor, by 21 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BDX or CRL?

BDX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BDX or CRL?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BDX or CRL?

CRL is the more resilient of the two, so the other name carries the higher downside risk. CRL on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BDX more profitable than CRL?

The profitability evidence is mixed: gross margin 46.1% vs 32.2%; operating margin 9.8% vs 12.3%; ttm roe 3.8% vs -7.7%. BDX leads on two measures and CRL on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is BDX's lead over CRL getting stronger or weaker?

BDX lead: Stable — the AIQ differential has held near 11 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has not changed hands in that window.

What would change the BDX vs CRL verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CRL closes the Value gap — currently 21 points behind, the largest single contributor to BDX's edge; CRL generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; BDX's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.

What do the current signals say about BDX and CRL?

BDX: 3 bullish / 3 bearish, conflicted. CRL: 4 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BDX is Death Cross Active (bearish, long horizon). On CRL it is Golden Cross Active (bullish, long horizon).

Compare BDX and CRL with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.